Search research articles
Contact Us
Filters
Showing results (41-50 of 175) with videos related to
Page
of 18
Sort By:
Nature Reviews. Drug Discovery
|
July 13, 2013
The 'rule of three' for fragment-based drug discovery: where are we now?
Harren Jhoti, Glyn Williams, David C Rees, et al.
Blood Reviews
|
June 24, 2022
Determinants of severity in sickle cell disease
David C Rees, Valentine A M Brousse, John N Brewin
British Journal of Haematology
|
November 30, 2004
Rituximab in chronic, recurrent HIV-associated immune thrombocytopenic purpura
Humayun N Ahmad, Colin Ball, Susan E Height, et al.
Rheumatology (Oxford, England)
|
March 29, 2016
Haemoglobinopathies and the rheumatologist
Michael Hughes, Qasim Akram, David C Rees, et al.
British Journal of Haematology
|
November 22, 2007
Serum lactate dehydrogenase activity as a biomarker in children with sickle cell disease
Sandra O'Driscoll, Susan E Height, Moira C Dick, et al.
American Journal of Hematology
|
April 27, 2026
Hydroxyurea Delays the Onset of Hyposplenism in Young Children With Sickle Cell Disease
Azalea A Khan, John N Brewin, Barnaby Clark, et al.
British Journal of Haematology
|
November 17, 2006
Cell-free DNA levels in pregnancies at risk of sickle-cell disease and significant ethnic variation
Ageliki Gerovassili, Kypros H Nicolaides, Swee Lay Thein, et al.
Journal of Medicinal Chemistry
|
October 15, 2016
Fragment-to-Lead Medicinal Chemistry Publications in 2015
Christopher N Johnson, Daniel A Erlanson, Christopher W Murray, et al.
Drug Discovery Today
|
July 19, 2005
Fragment-based lead discovery: leads by design
Robin A E Carr, Miles Congreve, Christopher W Murray, et al.
American Journal of Hematology
|
October 29, 2010
ENERCA clinical recommendations for disease management and prevention of complications of sickle cell disease in children
Mariane de Montalembert, Alina Ferster, Raffaella Colombatti, et al.
Page
of 18
Search research articles
Search
Showing results (41-50 of 175) with videos related to
Sort By:
Page
of 18
Nature Reviews. Drug Discovery
|
July 13, 2013
The 'rule of three' for fragment-based drug discovery: where are we now?
Harren Jhoti, Glyn Williams, David C Rees, et al.
Blood Reviews
|
June 24, 2022
Determinants of severity in sickle cell disease
David C Rees, Valentine A M Brousse, John N Brewin
British Journal of Haematology
|
November 30, 2004
Rituximab in chronic, recurrent HIV-associated immune thrombocytopenic purpura
Humayun N Ahmad, Colin Ball, Susan E Height, et al.
Rheumatology (Oxford, England)
|
March 29, 2016
Haemoglobinopathies and the rheumatologist
Michael Hughes, Qasim Akram, David C Rees, et al.
British Journal of Haematology
|
November 22, 2007
Serum lactate dehydrogenase activity as a biomarker in children with sickle cell disease
Sandra O'Driscoll, Susan E Height, Moira C Dick, et al.
American Journal of Hematology
|
April 27, 2026
Hydroxyurea Delays the Onset of Hyposplenism in Young Children With Sickle Cell Disease
Azalea A Khan, John N Brewin, Barnaby Clark, et al.
British Journal of Haematology
|
November 17, 2006
Cell-free DNA levels in pregnancies at risk of sickle-cell disease and significant ethnic variation
Ageliki Gerovassili, Kypros H Nicolaides, Swee Lay Thein, et al.
Journal of Medicinal Chemistry
|
October 15, 2016
Fragment-to-Lead Medicinal Chemistry Publications in 2015
Christopher N Johnson, Daniel A Erlanson, Christopher W Murray, et al.
Drug Discovery Today
|
July 19, 2005
Fragment-based lead discovery: leads by design
Robin A E Carr, Miles Congreve, Christopher W Murray, et al.
American Journal of Hematology
|
October 29, 2010
ENERCA clinical recommendations for disease management and prevention of complications of sickle cell disease in children
Mariane de Montalembert, Alina Ferster, Raffaella Colombatti, et al.
Page
of 18